Hikma Adds Sesen’s Vicineum To MENA Brands
Deal Allows Branded Cancer Treatment To Be Sold In 19 Markets
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
You may also be interested in...
Newly public Aligos will team with Merck & Co. on oligonucleotide therapies for NASH. Maze Therapeutics launches ophthalmology and CV-focused spinouts with Alloy and BridgeBio.
Hikma has provided a trading update that sheds fresh light on plans for its delayed Advair generic, as well as revealing some new launches.
The latest drug development news and highlights from our US FDA Performance Tracker.